The previous page is sending you to https://www.biospace.com/article/releases/actinium-highlights-foundational-patents-covering-the-composition-of-apamistamab-antibody-and-iomab-b-antibody-radiation-conjugate-for-targeted-conditioning-until-2037-and-recent-eu-patent-activity/.

 If you do not want to visit that page, you can return to the previous page.